How Peptide Nanostructures Are Enabling Targeted Drug Delivery and Precision Medicine | Research

The takeaway

A comprehensive review covers how self-assembling peptide nanostructures enable targeted drug delivery through tunable design, receptor-mediated cell entry, and disease-specific targeting for cancer and other precision medicine applications.

Tunable, targeted, biocompatible delivery
Peptide nanostructures combine self-assembly, receptor targeting, and cell-penetrating capabilities for disease-specific drug delivery in precision medicine

What the researchers found

The review covers several key aspects of peptide nanostructure-based drug delivery:

- Synthesis and self-assembly techniques: peptides and proteins can form diverse nanostructures (nanotubes, fibers, micelles, vesicles) with tunable properties

- Design strategies for enhanced stability, drug-loading capacity, and controlled release

- Cell interaction mechanisms: receptor-mediated endocytosis and cell-penetrating capabilities enable targeted delivery

- Biocompatibility and biomolecular recognition capacity make peptides ideal drug carriers

- Applications in precision medicine: personalized therapies and disease-specific targeting for diagnostics and therapeutics

- Cancer applications: tumor-specific targeting and delivery of therapeutic payloads

Why it matters

Current drug delivery systems often distribute drugs throughout the body, causing side effects. Peptide nanostructures can be programmed to deliver drugs specifically to diseased cells, improving effectiveness while reducing toxicity. Their biocompatibility (the body tolerates them well) and tunability make them ideal platforms for the growing field of precision medicine.

How the study worked

Comprehensive narrative review covering peptide and protein nanostructure design, synthesis, self-assembly, drug loading and release, cell interaction mechanisms, and applications in targeted drug delivery and precision medicine.

What this study cannot tell us

As a review article, no original data is presented. Many of the discussed applications are still in preclinical stages. The translation from lab-scale peptide nanostructure fabrication to clinical manufacturing remains challenging. Issues like batch-to-batch reproducibility, in vivo stability, and regulatory pathways for peptide nanomedicines are not fully resolved.

How to read the evidence

This is a comprehensive review article summarizing the current state of peptide nanostructure-based drug delivery research. It synthesizes preclinical and early clinical evidence without presenting original data.

When this study was published

Published in 2024, this review reflects the current state of the art in peptide nanomedicine and its applications in precision drug delivery.

The bigger picture

Peptide-based drug delivery is a rapidly growing field bridging nanotechnology and medicine. As precision medicine moves toward treating each patient's disease individually, peptide nanostructures offer the flexibility needed to customize drug delivery for specific diseases, tumor types, and even individual patients. The field intersects with advances in peptide chemistry, self-assembly science, and targeted therapy development.

Questions still open

Which peptide nanostructure architectures are closest to clinical translation for cancer drug delivery?
Can peptide nanostructures be manufactured at scale with sufficient reproducibility for regulatory approval?
How do peptide nanostructures compare to lipid nanoparticles (used in mRNA vaccines) for drug delivery efficiency?

Common questions

How do peptide nanostructures deliver drugs to specific cells?

Peptides can be designed with sequences that recognize specific receptors on target cells (like tumor cells). When these targeting peptides are built into nanostructures carrying drugs, they seek out the target cells, bind to their receptors, and get pulled inside through endocytosis — delivering the drug payload directly where it's needed.

Why use peptides instead of other nanoparticles for drug delivery?

Peptides are biocompatible (the body tolerates them well), biodegradable, and highly customizable. By changing the peptide sequence, scientists can tune the nanostructure's size, shape, stability, drug-loading capacity, and targeting ability. Their natural compatibility with biological systems gives them advantages over synthetic polymer or metal nanoparticles.

Read the original research

Therapeutic Peptides, Proteins and their Nanostructures for Drug Delivery and Precision Medicine.

Chembiochem : a European journal of chemical biology, 25(8), e202300831

View on PubMed ↗Publisher’s paper ↗

Citation

Kim, HaRam; Taslakjian, Boghos; Kim, Sarah; Tirrell, Matthew V; Guler, Mustafa O. (2024). Therapeutic Peptides, Proteins and their Nanostructures for Drug Delivery and Precision Medicine.. Chembiochem : a European journal of chemical biology, 25(8), e202300831. https://doi.org/10.1002/cbic.202300831